124 related articles for article (PubMed ID: 8276857)
1. Inhibition by heparin of thrombin-catalyzed activation of the factor VIII-von Willebrand factor complex.
Barrow RT; Healey JF; Lollar P
J Biol Chem; 1994 Jan; 269(1):593-8. PubMed ID: 8276857
[TBL] [Abstract][Full Text] [Related]
2. Differential proteolytic activation of factor VIII-von Willebrand factor complex by thrombin.
Hill-Eubanks DC; Parker CG; Lollar P
Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6508-12. PubMed ID: 2505252
[TBL] [Abstract][Full Text] [Related]
3. von Willebrand factor is a cofactor for thrombin-catalyzed cleavage of the factor VIII light chain.
Hill-Eubanks DC; Lollar P
J Biol Chem; 1990 Oct; 265(29):17854-8. PubMed ID: 2120219
[TBL] [Abstract][Full Text] [Related]
4. The effect of thrombin on the complex between factor VIII and von Willebrand factor.
Hamer RJ; Koedam JA; Beeser-Visser NH; Sixma JJ
Eur J Biochem; 1987 Sep; 167(2):253-9. PubMed ID: 3113951
[TBL] [Abstract][Full Text] [Related]
5. Slowed release of thrombin-cleaved factor VIII from von Willebrand factor by a monoclonal and a human antibody is a novel mechanism for factor VIII inhibition.
Saenko EL; Shima M; Gilbert GE; Scandella D
J Biol Chem; 1996 Nov; 271(44):27424-31. PubMed ID: 8910322
[TBL] [Abstract][Full Text] [Related]
6. Proteolysis at Arg740 facilitates subsequent bond cleavages during thrombin-catalyzed activation of factor VIII.
Newell JL; Fay PJ
J Biol Chem; 2007 Aug; 282(35):25367-75. PubMed ID: 17595160
[TBL] [Abstract][Full Text] [Related]
7. Purification and characterization of factor VIII 372-Cys: a hypofunctional cofactor from a patient with moderately severe hemophilia A.
O'Brien DP; Pattinson JK; Tuddenham EG
Blood; 1990 Apr; 75(8):1664-72. PubMed ID: 2109644
[TBL] [Abstract][Full Text] [Related]
8. The effect of plasma von Willebrand factor on the binding of human factor VIII to thrombin-activated human platelets.
Nesheim M; Pittman DD; Giles AR; Fass DN; Wang JH; Slonosky D; Kaufman RJ
J Biol Chem; 1991 Sep; 266(27):17815-20. PubMed ID: 1917924
[TBL] [Abstract][Full Text] [Related]
9. Interaction of the 268-282 region of glycoprotein Ibalpha with the heparin-binding site of thrombin inhibits the enzyme activation of factor VIII.
De Cristofaro R; De Filippis V
Biochem J; 2003 Jul; 373(Pt 2):593-601. PubMed ID: 12689334
[TBL] [Abstract][Full Text] [Related]
10. The physical exchange of factor VIII (FVIII) between von Willebrand factor and activated platelets and the effect of the FVIII B-domain on platelet binding.
Li X; Gabriel DA
Biochemistry; 1997 Sep; 36(35):10760-7. PubMed ID: 9271507
[TBL] [Abstract][Full Text] [Related]
11. The effect of von Willebrand factor on activation of factor VIII by factor Xa.
Koedam JA; Hamer RJ; Beeser-Visser NH; Bouma BN; Sixma JJ
Eur J Biochem; 1990 Apr; 189(2):229-34. PubMed ID: 2110896
[TBL] [Abstract][Full Text] [Related]
12. Characterization of calcium-dependent binding of endogenous factor VIII/von Willebrand factor to surface activated platelets.
Furby FH; Berndt MC; Castaldi PA; Koutts J
Thromb Res; 1984 Sep; 35(5):501-11. PubMed ID: 6435280
[TBL] [Abstract][Full Text] [Related]
13. Association of the factor VIII light chain with von Willebrand factor.
Lollar P; Hill-Eubanks DC; Parker CG
J Biol Chem; 1988 Jul; 263(21):10451-5. PubMed ID: 3134349
[TBL] [Abstract][Full Text] [Related]
14. Thrombin-activated and factor Xa-activated human factor VIII: differences in cofactor activity and decay rate.
Neuenschwander PF; Jesty J
Arch Biochem Biophys; 1992 Aug; 296(2):426-34. PubMed ID: 1632634
[TBL] [Abstract][Full Text] [Related]
15. Anti-heavy-chain monoclonal antibodies directed to the acidic regions of the factor VIII molecule inhibit the binding of factor VIII to phospholipids and von Willebrand factor.
Raut S; Villard S; Grailly S; Gilles JG; Granier C; Saint-Remy JM; Barrowcliffe TW
Thromb Haemost; 2003 Sep; 90(3):385-97. PubMed ID: 12958606
[TBL] [Abstract][Full Text] [Related]
16. A monoclonal antibody (NMC-VIII/10) to factor VIII light chain recognizing Glu1675-Glu1684 inhibits factor VIII binding to endogenous von Willebrand factor in human umbilical vein endothelial cells.
Shima M; Yoshioka A; Nakajima M; Nakai H; Fukui H
Br J Haematol; 1992 Aug; 81(4):533-8. PubMed ID: 1390241
[TBL] [Abstract][Full Text] [Related]
17. A monoclonal antibody to factor VIII inhibits von Willebrand factor binding and thrombin cleavage.
Precup JW; Kline BC; Fass DN
Blood; 1991 May; 77(9):1929-36. PubMed ID: 1902121
[TBL] [Abstract][Full Text] [Related]
18. Effect of multimerization of human and recombinant von Willebrand factor on platelet aggregation, binding to collagen and binding of coagulation factor VIII.
Fischer BE; Kramer G; Mitterer A; Grillberger L; Reiter M; Mundt W; Dorner F; Eibl J
Thromb Res; 1996 Oct; 84(1):55-66. PubMed ID: 8885147
[TBL] [Abstract][Full Text] [Related]
19. Elevated plasma factor VIII enhances venous thrombus formation in rabbits: contribution of factor XI, von Willebrand factor and tissue factor.
Sugita C; Yamashita A; Matsuura Y; Iwakiri T; Okuyama N; Matsuda S; Matsumoto T; Inoue O; Harada A; Kitazawa T; Hattori K; Shima M; Asada Y
Thromb Haemost; 2013 Jul; 110(1):62-75. PubMed ID: 23636277
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms for inhibition of the generation of thrombin activity by sulfated polysaccharides.
Ofosu FA; Modi GJ; Hirsh J; Buchanan MR; Blajchman MA
Ann N Y Acad Sci; 1986; 485():41-55. PubMed ID: 2436525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
